Optimizing COVID-19 Candidate Therapeutics: Thinking Without Borders

Craig R. Rayner; Patrick F. Smith; Kevin Hershberger; David Wesche

doi:10.1111/cts.12790

Optimizing COVID-19 Candidate Therapeutics: Thinking Without Borders

Craig R. Rayner
, Patrick F. Smith
, Kevin Hershberger
, David Wesche

Pharmacy

Certara

Research output: Contribution to journal › Comment/debate

11 Scopus citations

Original language	English
Pages (from-to)	830-834
Number of pages	5
Journal	Clinical and Translational Science
Volume	13
Issue number	5
DOIs	https://doi.org/10.1111/cts.12790
State	Published - Sep 1 2020

Access to Document

10.1111/cts.12790

Cite this

@article{cb02806ee9b449268f358f438a7959fd,

title = "Optimizing COVID-19 Candidate Therapeutics: Thinking Without Borders",

author = "Rayner, \{Craig R.\} and Smith, \{Patrick F.\} and Kevin Hershberger and David Wesche",

year = "2020",

month = sep,

day = "1",

doi = "10.1111/cts.12790",

language = "English",

volume = "13",

pages = "830--834",

journal = "Clinical and Translational Science",

issn = "1752-8054",

publisher = "John Wiley and Sons Inc",

number = "5",

}

TY - JOUR

T1 - Optimizing COVID-19 Candidate Therapeutics

T2 - Thinking Without Borders

AU - Rayner, Craig R.

AU - Smith, Patrick F.

AU - Hershberger, Kevin

AU - Wesche, David

PY - 2020/9/1

Y1 - 2020/9/1

UR - https://www.scopus.com/pages/publications/85083225095

U2 - 10.1111/cts.12790

DO - 10.1111/cts.12790

M3 - Comment/debate

C2 - 32212378

AN - SCOPUS:85083225095

SN - 1752-8054

VL - 13

SP - 830

EP - 834

JO - Clinical and Translational Science

JF - Clinical and Translational Science

IS - 5

ER -

Optimizing COVID-19 Candidate Therapeutics: Thinking Without Borders

Access to Document

Other files and links

Fingerprint

Cite this